Cognitive-Behavioral Therapy for Anorexia
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Massachusetts General Hospital
No Placebo Group
Trial Summary
What is the purpose of this trial?
The study is a clinical trial assessing the efficacy of a new twenty session cognitive behavioral therapy for adults (18+) with anorexia nervosa (AN). It is expected that participants will gain a significant amount of weight and experience a significant decrease in eating disorder psychopathology and behavior from pre- to post- treatment and that this will be retained after 6-months.
Eligibility Criteria
Adults aged 18 and over with anorexia nervosa can join this study. The trial is designed to help them gain weight and reduce eating disorder behaviors. Participants must be able to attend twenty therapy sessions.Inclusion Criteria
I am older than 18 years.
Eligible patients must meet DSM-5 criteria for anorexia nervosa. This diagnosis can be conferred via the EDE 17.0D.
Patients must be able to provide informed consent and comply with the study procedures.
See 2 more
Exclusion Criteria
Homicidal ideation
Systolic BP (SBP and DBP) <80 or >160, obtained via patient medical chart or from study 2023P000469 or 2018P002915.
Temperature < 96.5 F, obtained via patient medical chart or from study 2023P000469 or 2018P002915.
See 12 more
Treatment Details
Interventions
- Twenty Session Cognitive-Behavioral Therapy for Anorexia Nervosa (CBT-20-AN) (Behavioral Intervention)
Trial OverviewThe trial tests a new twenty-session cognitive-behavioral therapy (CBT-20-AN) specifically for adults with anorexia nervosa, aiming to see if it helps patients gain weight and improve their relationship with food.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: CBT-20-ANExperimental Treatment1 Intervention
The single CBT-20-AN arm of this study is experimental, consisting of 20 weekly sessions and one-month, three-month, and six-month follow-ups.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Massachusetts General Hospital
Lead Sponsor
Trials
3,066
Recruited
13,430,000+